Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the third quarter ended September 30 ...
Syantra, Inc., a precision biotechnology company revolutionizing early cancer detection, today announced a clinical research partnership with Breast Cancer Foundation NZ. The partnership is a critical ...